Medical air pressure control cabinets

InformationSP-96 is a potent, selective and non-ATP-competitive inhibitor ofAurora Bwith IC50 of 0.316 nM. SP-96 can be used for the research of triple negative breast cancer (TNBC).TargetsAurora B (Cell-free assay) 0.316 nMIn vitroSP-96 shows

InformationSP-96 is a potent, selective and non-ATP-competitive inhibitor ofAurora Bwith IC50 of 0.316 nM. SP-96 can be used for the research of triple negative breast cancer (TNBC).TargetsAurora B (Cell-free assay) 0.316 nMIn vitroSP-96 shows

InformationSP-96 is a potent, selective and non-ATP-competitive inhibitor ofAurora Bwith IC50 of 0.316 nM. SP-96 can be used for the research of triple negative breast cancer (TNBC).TargetsAurora B (Cell-free assay) 0.316 nMIn vitroSP-96 shows

InformationSP-96 is a potent, selective and non-ATP-competitive inhibitor ofAurora Bwith IC50 of 0.316 nM. SP-96 can be used for the research of triple negative breast cancer (TNBC).TargetsAurora B (Cell-free assay) 0.316 nMIn vitroSP-96 shows

InformationSP-96 is a potent, selective and non-ATP-competitive inhibitor ofAurora Bwith IC50 of 0.316 nM. SP-96 can be used for the research of triple negative breast cancer (TNBC).TargetsAurora B (Cell-free assay) 0.316 nMIn vitroSP-96 shows

PF-8380 is a potent and specific autotaxin inhibitor with an IC50 value of 2.8 nM.A substrate competitive and tight-binding inhibitor of autotaxin.

PF-8380 is a potent and specific autotaxin inhibitor with an IC50 value of 2.8 nM.A substrate competitive and tight-binding inhibitor of autotaxin.

PF-8380 is a potent and specific autotaxin inhibitor with an IC50 value of 2.8 nM.A substrate competitive and tight-binding inhibitor of autotaxin.

PF-8380 is a potent and specific autotaxin inhibitor with an IC50 value of 2.8 nM.A substrate competitive and tight-binding inhibitor of autotaxin.

InformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B

InformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B

InformationCFI-400945 CFI-400945 is an orally active, potent and selective polo-like kinase 4(PLK4) inhibitor with Ki value of 0.26 nM.TargetsPLK4 (Cell-free assay): TrkA (Cell-free assay): TrkB (Cell-free assay): Tie-2 (Cell-free assay): Aurora B